Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour
Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a sup...
Saved in:
Published in | NPJ precision oncology Vol. 2; no. 1; p. 26 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
19.11.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 2397-768X 2397-768X |
DOI | 10.1038/s41698-018-0069-7 |
Cover
Abstract | Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations.
Diagnostics: Proton state of secreted proteins in blood helps identify cancer
A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio
from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer. |
---|---|
AbstractList | Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual's diagnosis and/or help clarify risk in healthy populations.Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual's diagnosis and/or help clarify risk in healthy populations. Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer. Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations. Diagnostics: Proton state of secreted proteins in blood helps identify cancer A blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer. Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma. The protonation state (PS) of secretome reflects the metabolism of cells and can be used for cancer early detection. Here, we demonstrate a superhydrophobic organic electrochemical device that measures PS in a drop of secretome derived from liquid biopsies. Using data from the sensor and principal component analysis (PCA), we developed algorithms able to efficiently discriminate tumour patients from non-tumour patients. We then validated the results using mass spectrometry and biochemical analysis of samples. For the 36 patients across three independent cohorts, the method identified tumour patients with high sensitivity and identification as high as 100% (no false positives) with declared subjects at-risk, for sporadic cancer onset, by intermediate values of PS. This assay could impact on cancer risk management, individual’s diagnosis and/or help clarify risk in healthy populations.Diagnostics: Proton state of secreted proteins in blood helps identify cancerA blood test that measures whether molecules secreted by cells contain titratable proton atoms can accurately discriminate between patients who have cancer and those who don’t. Titratable species may in turn influence the protonation state of a solution, i.e. the number of protons added to and the net charge of that solution. A team led by Natalia Malara from University Magna Graecia in Catanzaro, Italy and Enzo Di Fabrizio from the King Abdullah University of Science and Technology in Thuwal, Saudi Arabia, Francesco Gentile from the University Federico II in Naples, Italy, and Nicola Coppedè from the Institute of Materials for Electronics and Magnetism in Parma, Italy, created an eletrochemical device that can detect faulty metabolism by quantifying the proportion of secreted proteins with and without extra protons—an indicator of abnormal cell division, proliferation and invasion. The researchers tested the device on blood samples from patients with solid tumors and healthy controls. The method identified cancer patients with a high degree of accuracy. If the findings are confirmed in larger trials, the test could help with the screening, diagnosis and management of cancer. |
ArticleNumber | 26 |
Author | Mollace, V. Onesto, V. Scali, E. Bonacci, S. Innaro, N. Castellini, A. Coppedè, N. Gentile, F. Perozziello, G. Volpentesta, G. Donato, A. Ferrara, L. Givigliano, F. Sena, G. Malara, N. Casale, F. Candeloro, P. Maisano, D. Donato, G. Sacco, R. Giannetto, M. Scumaci, D. Coluccio, M. L. Majewska, R. Lavano, A. Ferraro, E. Greco, M. Renne, M. Trunzo, V. Guzzi, G. Amato, F. Bottoni, U. Mignogna, C. Di Fabrizio, E. Voci, C. Careri, M. Presta, I. Cuda, G. Pirrone, C. K. |
Author_xml | – sequence: 1 givenname: N. orcidid: 0000-0002-1719-293X surname: Malara fullname: Malara, N. email: nataliamalara@unicz.it organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 2 givenname: F. surname: Gentile fullname: Gentile, F. organization: Department of Electrical Engineering and Information Technology, University Federico II – sequence: 3 givenname: N. orcidid: 0000-0001-5715-4236 surname: Coppedè fullname: Coppedè, N. organization: Institute of Materials for Electronics and Magnetism IMEM CNR Parco Area delle Scienze – sequence: 4 givenname: M. L. orcidid: 0000-0002-9987-2348 surname: Coluccio fullname: Coluccio, M. L. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 5 givenname: P. surname: Candeloro fullname: Candeloro, P. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 6 givenname: G. surname: Perozziello fullname: Perozziello, G. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 7 givenname: L. surname: Ferrara fullname: Ferrara, L. organization: Centre of Medical Physics and Biomedical Engineering, Medical University of Vienna – sequence: 8 givenname: M. surname: Giannetto fullname: Giannetto, M. organization: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma – sequence: 9 givenname: M. surname: Careri fullname: Careri, M. organization: Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma – sequence: 10 givenname: A. surname: Castellini fullname: Castellini, A. organization: Institute of Materials for Electronics and Magnetism IMEM CNR Parco Area delle Scienze – sequence: 11 givenname: C. orcidid: 0000-0001-5576-4946 surname: Mignogna fullname: Mignogna, C. organization: Department of Health Science, University Magna Graecia – sequence: 12 givenname: I. surname: Presta fullname: Presta, I. organization: Department of Health Science, University Magna Graecia – sequence: 13 givenname: C. K. surname: Pirrone fullname: Pirrone, C. K. organization: Department of Health Science, University Magna Graecia – sequence: 14 givenname: D. surname: Maisano fullname: Maisano, D. organization: Department of Health Science, University Magna Graecia – sequence: 15 givenname: A. surname: Donato fullname: Donato, A. organization: Department of Health Science, University Magna Graecia – sequence: 16 givenname: G. surname: Donato fullname: Donato, G. organization: Department of Health Science, University Magna Graecia – sequence: 17 givenname: M. surname: Greco fullname: Greco, M. organization: Department of Health Science, University Magna Graecia – sequence: 18 givenname: D. surname: Scumaci fullname: Scumaci, D. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 19 givenname: G. orcidid: 0000-0001-6313-1866 surname: Cuda fullname: Cuda, G. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 20 givenname: F. surname: Casale fullname: Casale, F. organization: Department of Health Science, University Magna Graecia – sequence: 21 givenname: E. surname: Ferraro fullname: Ferraro, E. organization: Department of Clinical and Biological Sciences, University of Torino – sequence: 22 givenname: S. surname: Bonacci fullname: Bonacci, S. organization: Department of Health Science, University Magna Graecia – sequence: 23 givenname: V. surname: Trunzo fullname: Trunzo, V. organization: Department of Health Science, University Magna Graecia – sequence: 24 givenname: V. surname: Mollace fullname: Mollace, V. organization: Department of Health Science, University Magna Graecia – sequence: 25 givenname: V. orcidid: 0000-0002-2308-4126 surname: Onesto fullname: Onesto, V. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 26 givenname: R. surname: Majewska fullname: Majewska, R. organization: School of Biological Sciences, North-West University – sequence: 27 givenname: F. surname: Amato fullname: Amato, F. organization: Department of Experimental and Clinical Medicine, University Magna Graecia – sequence: 28 givenname: M. surname: Renne fullname: Renne, M. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 29 givenname: N. surname: Innaro fullname: Innaro, N. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 30 givenname: G. orcidid: 0000-0001-9793-3250 surname: Sena fullname: Sena, G. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 31 givenname: R. surname: Sacco fullname: Sacco, R. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 32 givenname: F. surname: Givigliano fullname: Givigliano, F. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 33 givenname: C. surname: Voci fullname: Voci, C. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 34 givenname: G. surname: Volpentesta fullname: Volpentesta, G. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 35 givenname: G. surname: Guzzi fullname: Guzzi, G. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 36 givenname: A. surname: Lavano fullname: Lavano, A. organization: Department of Surgical and Medical Science University Magna Graecia – sequence: 37 givenname: E. surname: Scali fullname: Scali, E. organization: Department of Health Science, University Magna Graecia – sequence: 38 givenname: U. surname: Bottoni fullname: Bottoni, U. organization: Department of Health Science, University Magna Graecia – sequence: 39 givenname: E. surname: Di Fabrizio fullname: Di Fabrizio, E. email: Enzo.DiFabrizio@KAUST.EDU organization: Physical Science & Engineering Division, King Abdullah University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30480095$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUFv1DAQhSNUREvpD-CCLHHhEnCcxLEvSKiigFSJAyBxsybJpOuS2MHjFC2n_nQcdqGlEoiDZcv-3vPMm4fZgfMOs-xxwZ8XvFQvqCqkVjkv0uJS58297EiUuskbqT4f3DofZidEl5wnsi6ElA-yw5JXinNdH2XXH5YZw2bbBz9vfGs7NkKbe5d3GzuzCYGWgMQIu4DRT8jm4KN3EK13jCJEZOD69fbK9gkEluwoAaP9jj0Llr4wIEKiCV1kfmA0-wB9-iguk1_Co-z-ACPhyX4_zj6dvf54-jY_f__m3emr87yrGh5zOYiiUjVIUIPqZKuE0EOJ2NZ9JZtWtkNX1whDKZu65VooAcCFxqpGXQ0CyuNM7HwXN8P2G4yjmYOdIGxNwc2aqNklalJOZk3UNEn0cieal3bCvkstBLgRerDmzxdnN-bCXxkpKqHr1eDZ3iD4rwtSNJOlDscRHPqFjChKJUutS5nQp3fQyxRPCjJRpdKNSANcDZ_cruh3Kb8mmoBiB3TBEwUc_qvN5o6ms_HniFNTdvyncp8qpV_cBYabov8u-gHS89lQ |
CitedBy_id | crossref_primary_10_1016_j_addr_2020_09_011 crossref_primary_10_3390_nano11092432 crossref_primary_10_1002_cam4_4813 crossref_primary_10_1016_j_esmorw_2024_100046 crossref_primary_10_1016_j_trac_2019_05_043 crossref_primary_10_1186_s11671_021_03489_z crossref_primary_10_1111_wrr_13251 crossref_primary_10_18632_oncotarget_27990 crossref_primary_10_1021_acsami_1c15981 crossref_primary_10_1155_2021_8841911 crossref_primary_10_1109_JSEN_2019_2940993 crossref_primary_10_3390_ijms21134711 crossref_primary_10_3389_fonc_2021_737730 crossref_primary_10_3390_mi11020123 crossref_primary_10_1016_j_orgel_2019_105579 crossref_primary_10_3390_cancers14194676 |
Cites_doi | 10.1021/bi101933p 10.1016/j.bbadis.2003.08.002 10.3389/fonc.2015.00115 10.1038/srep18992 10.1016/j.orgel.2016.05.001 10.1038/s41467-017-01174-3 10.3390/ijms18091852 10.1002/smll.201201377 10.1155/2014/302694 10.1371/journal.pone.0129762 10.1038/srep24517 10.1126/science.1242072 10.1016/j.mee.2013.01.036 10.1021/ja055762e 10.1073/pnas.1719264115 10.3322/caac.21443 10.1088/0957-4484/25/48/485703 10.1186/s12967-016-0876-y 10.1021/pr2012347 10.1016/S0378-4274(99)00160-5 10.1038/533304a 10.1006/niox.1997.0141 10.1038/srep04297 |
ContentType | Journal Article |
Copyright | The Author(s) 2018 The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2018 – notice: The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
DOI | 10.1038/s41698-018-0069-7 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2397-768X |
ExternalDocumentID | 10.1038/s41698-018-0069-7 PMC6242957 30480095 10_1038_s41698_018_0069_7 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | 0R~ 53G 7RV 7X7 8FI 8FJ AAJSJ AAKAB ABUWG ACGFS ACSMW ADBBV AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR C6C CCPQU EBLON EBS EJD FYUFA GROUPED_DOAJ HMCUK HYE M~E NAO NAPCQ NO~ OK1 PGMZT PIMPY RNT RPM SNYQT UKHRP AASML AAYXX CITATION PHGZM PHGZT PPXIY PUEGO EMOBN KQ8 NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c470t-6f21485a6a8f8c6b8229f3eeb5d467b6bfc55eaf3675b09282aa029e45e94f2a3 |
IEDL.DBID | BENPR |
ISSN | 2397-768X |
IngestDate | Wed Aug 20 00:04:23 EDT 2025 Tue Sep 30 16:57:14 EDT 2025 Wed Oct 01 14:06:52 EDT 2025 Fri Jul 25 04:51:42 EDT 2025 Wed Feb 19 02:42:15 EST 2025 Thu Apr 24 22:59:36 EDT 2025 Wed Oct 01 00:59:44 EDT 2025 Fri Feb 21 02:39:57 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c470t-6f21485a6a8f8c6b8229f3eeb5d467b6bfc55eaf3675b09282aa029e45e94f2a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1719-293X 0000-0002-9987-2348 0000-0001-5715-4236 0000-0002-2308-4126 0000-0001-5576-4946 0000-0001-9793-3250 0000-0001-6313-1866 |
OpenAccessLink | https://www.proquest.com/docview/2389720017?pq-origsite=%requestingapplication%&accountid=15518 |
PMID | 30480095 |
PQID | 2389720017 |
PQPubID | 4669714 |
ParticipantIDs | unpaywall_primary_10_1038_s41698_018_0069_7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6242957 proquest_miscellaneous_2138639936 proquest_journals_2389720017 pubmed_primary_30480095 crossref_primary_10_1038_s41698_018_0069_7 crossref_citationtrail_10_1038_s41698_018_0069_7 springer_journals_10_1038_s41698_018_0069_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-11-19 |
PublicationDateYYYYMMDD | 2018-11-19 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-19 day: 19 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | NPJ precision oncology |
PublicationTitleAbbrev | npj Precision Onc |
PublicationTitleAlternate | NPJ Precis Oncol |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Malara (CR11) 2014; 28 Rodriguez, Laio (CR19) 2014; 344 AA (CR27) 2005; 127 Tsai (CR3) 2016; 6 Coppedè (CR18) 2014; 25 Kalapos (CR9) 1999; 110 Tamae, Lim, Wuenschell, Termini (CR10) 2011; 50 Raso (CR22) 2012; 11 Brady (CR6) 2017; 8 Gentile (CR13) 2014; 2014 Limongi (CR26) 2013; 9 Kaiser (CR4) 2018; 19 Hong (CR5) 2018; 10 Malara (CR12) 2016; 14 Heidi (CR2) 2016; 533 Gentile (CR17) 2013; 111 Gaudry-Talarmain (CR24) 2002; 1 Gentile (CR14) 2016; 6 Gentile (CR16) 2016; 35 Carrera, Hagop, Blinder (CR1) 2018; 68 Malara (CR8) 2016; 1 CR20 Vizoso, Eiro, Cid, Schneider, Perez-Fernandez (CR7) 2017; 18 Coppedè, Villani, Gentile (CR15) 2014; 4 Ahmed (CR23) 2003; 1639 Scumaci (CR25) 2015; 10 Wagner, Wiig (CR21) 2015; 5 NM Malara (69_CR11) 2014; 28 FML Gentile (69_CR17) 2013; 111 N Coppedè (69_CR18) 2014; 25 PM Carrera (69_CR1) 2018; 68 A Rodriguez (69_CR19) 2014; 344 69_CR20 Yu AA (69_CR27) 2005; 127 F Gentile (69_CR14) 2016; 6 D Scumaci (69_CR25) 2015; 10 N Malara (69_CR12) 2016; 14 L Heidi (69_CR2) 2016; 533 F Gentile (69_CR16) 2016; 35 YM Gaudry-Talarmain (69_CR24) 2002; 1 FJ Vizoso (69_CR7) 2017; 18 MP Kalapos (69_CR9) 1999; 110 D Tamae (69_CR10) 2011; 50 F Gentile (69_CR13) 2014; 2014 M Wagner (69_CR21) 2015; 5 WS Tsai (69_CR3) 2016; 6 N Ahmed (69_CR23) 2003; 1639 N Coppedè (69_CR15) 2014; 4 N Malara (69_CR8) 2016; 1 X Hong (69_CR5) 2018; 10 C Raso (69_CR22) 2012; 11 T Limongi (69_CR26) 2013; 9 J Kaiser (69_CR4) 2018; 19 SW Brady (69_CR6) 2017; 8 27176720 - J Transl Med. 2016 May 12;14(1):133 26061043 - PLoS One. 2015 Jun 10;10(6):e0129762 28841158 - Int J Mol Sci. 2017 Aug 25;18(9):null 14559119 - Biochim Biophys Acta. 2003 Oct 15;1639(2):121-32 9441905 - Nitric Oxide. 1997 Aug;1(4):330-45 23027505 - Small. 2013 Feb 11;9(3):402-12 27193658 - Nature. 2016 May 18;533(7603):304-5 27075165 - Sci Rep. 2016 Apr 14;6:24517 26753611 - Sci Rep. 2016 Jan 12;6:18992 26075182 - Front Oncol. 2015 May 26;5:115 29338071 - CA Cancer J Clin. 2018 Mar;68(2):153-165 24599076 - Sci Rep. 2014 Mar 06;4:4297 10597025 - Toxicol Lett. 1999 Nov 22;110(3):145-75 24579079 - Biomed Res Int. 2014;2014:302694 16316209 - J Am Chem Soc. 2005 Dec 7;127(48):16774-5 29348215 - Science. 2018 Jan 19;359(6373):259 21355561 - Biochemistry. 2011 Mar 29;50(12):2321-9 22563702 - J Proteome Res. 2012 Jun 1;11(6):3199-210 24970081 - Science. 2014 Jun 27;344(6191):1492-6 25388936 - Nanotechnology. 2014 Dec 5;25(48):485703 29093439 - Nat Commun. 2017 Nov 1;8(1):1231 25620181 - J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):717-31 29453278 - Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2467-2472 |
References_xml | – volume: 50 start-page: 2321 year: 2011 end-page: 2329 ident: CR10 article-title: Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2′- deoxyguanosine in human cells publication-title: Biochemistry doi: 10.1021/bi101933p – volume: 1639 start-page: 121 year: 2003 end-page: 132 ident: CR23 article-title: Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2003.08.002 – volume: 5 start-page: 115 year: 2015 ident: CR21 article-title: Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications publication-title: Front. Oncol. doi: 10.3389/fonc.2015.00115 – volume: 6 start-page: 1 year: 2016 end-page: 15 ident: CR14 article-title: Geometrical patterning of super-hydrophobic biosensing transistors enables space and time resolved analysis of biological mixtures publication-title: Sci. Rep. doi: 10.1038/srep18992 – volume: 35 start-page: 59 year: 2016 end-page: 64 ident: CR16 article-title: A theoretical model for the time varying current in organic electrochemical transistors in a dynamic regime Organic Electronics publication-title: Org. Electron. doi: 10.1016/j.orgel.2016.05.001 – volume: 19 start-page: 359 year: 2018 end-page: 259 ident: CR4 article-title: Liquid biopsy’ for cancer promises early detection publication-title: Science – volume: 28 start-page: 717 year: 2014 end-page: 731 ident: CR11 article-title: In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients publication-title: J. Biol. Regul. Homeost. Agents – volume: 8 year: 2017 ident: CR6 article-title: Combating subclonal evolution of resistant cancer phenotypes publication-title: Nat. Commun. doi: 10.1038/s41467-017-01174-3 – volume: 4 start-page: 1 year: 2014 end-page: 7 ident: CR15 article-title: Diffusion driven selectivity in organic electrochemical transistors publication-title: Sci. Rep. – volume: 18 start-page: 1852 year: 2017 ident: CR7 article-title: Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18091852 – volume: 9 start-page: 402 year: 2013 end-page: 412 ident: CR26 article-title: Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks publication-title: Small doi: 10.1002/smll.201201377 – volume: 2014 start-page: 1 year: 2014 end-page: 10 ident: CR13 article-title: Microtexturing of the conductive PEDOT: PSS polymer for superhydrophobic organic electrochemical transistors publication-title: Biomed. Res. Int. doi: 10.1155/2014/302694 – volume: 10 year: 2015 ident: CR25 article-title: Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: diagnostic and functional implications publication-title: PLoS ONE doi: 10.1371/journal.pone.0129762 – volume: 6 year: 2016 ident: CR3 article-title: Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients publication-title: Sci. Rep. doi: 10.1038/srep24517 – volume: 344 start-page: 1492 year: 2014 end-page: 1496 ident: CR19 article-title: Clustering by fast search and find of density peaks publication-title: Science doi: 10.1126/science.1242072 – volume: 111 start-page: 272 year: 2013 end-page: 276 ident: CR17 article-title: Non periodic patterning of super-hydrophobic surfaces forthe manipulation of few molecules publication-title: Microelectron. Eng. doi: 10.1016/j.mee.2013.01.036 – volume: 127 start-page: 16774 year: 2005 end-page: 16775 ident: CR27 article-title: resolution printing of DNA feature on poly(methyl methacrylate) substrates using supramolecular nano-stamping publication-title: J. Am. Chem. Soc. doi: 10.1021/ja055762e – volume: 10 start-page: 2467 year: 2018 end-page: 2472 ident: CR5 article-title: Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1719264115 – volume: 68 start-page: 153 year: 2018 end-page: 165 ident: CR1 article-title: The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21443 – volume: 25 start-page: 485703 year: 2014 ident: CR18 article-title: Titanyl phthalocyanine ambipolar thin film transistors making use of carbon nanotube electrodes publication-title: Nanotechnology doi: 10.1088/0957-4484/25/48/485703 – volume: 14 year: 2016 ident: CR12 article-title: Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provided useful biomarker for personalized metastatic risk assessment publication-title: J. Transl. Med. doi: 10.1186/s12967-016-0876-y – volume: 11 start-page: 3199 year: 2012 end-page: 3210 ident: CR22 article-title: Characterization of breast cancer interstitial fluids by TmT labeling, LTQOrbitrap Velos mass spectrometry, and pathway analysis publication-title: J. Proteome Res. doi: 10.1021/pr2012347 – volume: 1 start-page: 3545 year: 2016 end-page: 3552 ident: CR8 article-title: Tailoring super- hydrophobic properties of electrochemical biosensor for early cancer detection publication-title: Soft Mater. Biomater. – volume: 110 start-page: 145 year: 1999 end-page: 175 ident: CR9 article-title: Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications publication-title: Toxicol. Lett. doi: 10.1016/S0378-4274(99)00160-5 – volume: 533 start-page: 304 year: 2016 end-page: 305 ident: CR2 article-title: Bankruptcy of nanomedicine firm worries drug developers publication-title: Nature doi: 10.1038/533304a – volume: 1 start-page: 330 year: 2002 end-page: 345 ident: CR24 article-title: Nitric oxide and peroxynitrite affect differently acetylcholine release, choline acetyltransferase activity, synthesis, and compartmentation of newly formed acetylcholine in Torpedo marmorata synaptosomes publication-title: Nitric Oxide-Biol. Chem. doi: 10.1006/niox.1997.0141 – ident: CR20 – volume: 28 start-page: 717 year: 2014 ident: 69_CR11 publication-title: J. Biol. Regul. Homeost. Agents – volume: 111 start-page: 272 year: 2013 ident: 69_CR17 publication-title: Microelectron. Eng. doi: 10.1016/j.mee.2013.01.036 – volume: 533 start-page: 304 year: 2016 ident: 69_CR2 publication-title: Nature doi: 10.1038/533304a – volume: 4 start-page: 1 year: 2014 ident: 69_CR15 publication-title: Sci. Rep. doi: 10.1038/srep04297 – volume: 19 start-page: 359 year: 2018 ident: 69_CR4 publication-title: Science – volume: 10 start-page: 2467 year: 2018 ident: 69_CR5 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1719264115 – volume: 1 start-page: 3545 year: 2016 ident: 69_CR8 publication-title: Soft Mater. Biomater. – volume: 1639 start-page: 121 year: 2003 ident: 69_CR23 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2003.08.002 – volume: 5 start-page: 115 year: 2015 ident: 69_CR21 publication-title: Front. Oncol. doi: 10.3389/fonc.2015.00115 – volume: 68 start-page: 153 year: 2018 ident: 69_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21443 – volume: 25 start-page: 485703 year: 2014 ident: 69_CR18 publication-title: Nanotechnology doi: 10.1088/0957-4484/25/48/485703 – volume: 35 start-page: 59 year: 2016 ident: 69_CR16 publication-title: Org. Electron. doi: 10.1016/j.orgel.2016.05.001 – volume: 14 year: 2016 ident: 69_CR12 publication-title: J. Transl. Med. doi: 10.1186/s12967-016-0876-y – ident: 69_CR20 – volume: 6 start-page: 1 year: 2016 ident: 69_CR14 publication-title: Sci. Rep. doi: 10.1038/srep18992 – volume: 127 start-page: 16774 year: 2005 ident: 69_CR27 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja055762e – volume: 18 start-page: 1852 year: 2017 ident: 69_CR7 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18091852 – volume: 9 start-page: 402 year: 2013 ident: 69_CR26 publication-title: Small doi: 10.1002/smll.201201377 – volume: 8 year: 2017 ident: 69_CR6 publication-title: Nat. Commun. doi: 10.1038/s41467-017-01174-3 – volume: 2014 start-page: 1 year: 2014 ident: 69_CR13 publication-title: Biomed. Res. Int. doi: 10.1155/2014/302694 – volume: 50 start-page: 2321 year: 2011 ident: 69_CR10 publication-title: Biochemistry doi: 10.1021/bi101933p – volume: 1 start-page: 330 year: 2002 ident: 69_CR24 publication-title: Nitric Oxide-Biol. Chem. doi: 10.1006/niox.1997.0141 – volume: 110 start-page: 145 year: 1999 ident: 69_CR9 publication-title: Toxicol. Lett. doi: 10.1016/S0378-4274(99)00160-5 – volume: 344 start-page: 1492 year: 2014 ident: 69_CR19 publication-title: Science doi: 10.1126/science.1242072 – volume: 6 year: 2016 ident: 69_CR3 publication-title: Sci. Rep. doi: 10.1038/srep24517 – volume: 11 start-page: 3199 year: 2012 ident: 69_CR22 publication-title: J. Proteome Res. doi: 10.1021/pr2012347 – volume: 10 year: 2015 ident: 69_CR25 publication-title: PLoS ONE doi: 10.1371/journal.pone.0129762 – reference: 22563702 - J Proteome Res. 2012 Jun 1;11(6):3199-210 – reference: 16316209 - J Am Chem Soc. 2005 Dec 7;127(48):16774-5 – reference: 23027505 - Small. 2013 Feb 11;9(3):402-12 – reference: 26075182 - Front Oncol. 2015 May 26;5:115 – reference: 10597025 - Toxicol Lett. 1999 Nov 22;110(3):145-75 – reference: 24599076 - Sci Rep. 2014 Mar 06;4:4297 – reference: 25388936 - Nanotechnology. 2014 Dec 5;25(48):485703 – reference: 24579079 - Biomed Res Int. 2014;2014:302694 – reference: 29093439 - Nat Commun. 2017 Nov 1;8(1):1231 – reference: 27176720 - J Transl Med. 2016 May 12;14(1):133 – reference: 25620181 - J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):717-31 – reference: 14559119 - Biochim Biophys Acta. 2003 Oct 15;1639(2):121-32 – reference: 29348215 - Science. 2018 Jan 19;359(6373):259 – reference: 27193658 - Nature. 2016 May 18;533(7603):304-5 – reference: 24970081 - Science. 2014 Jun 27;344(6191):1492-6 – reference: 29338071 - CA Cancer J Clin. 2018 Mar;68(2):153-165 – reference: 9441905 - Nitric Oxide. 1997 Aug;1(4):330-45 – reference: 26753611 - Sci Rep. 2016 Jan 12;6:18992 – reference: 21355561 - Biochemistry. 2011 Mar 29;50(12):2321-9 – reference: 26061043 - PLoS One. 2015 Jun 10;10(6):e0129762 – reference: 29453278 - Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2467-2472 – reference: 28841158 - Int J Mol Sci. 2017 Aug 25;18(9):null – reference: 27075165 - Sci Rep. 2016 Apr 14;6:24517 |
SSID | ssj0001851266 |
Score | 2.2005186 |
Snippet | Secretome of primary cultures is an accessible source of biological markers compared to more complex and less decipherable mixtures such as serum or plasma.... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 26 |
SubjectTerms | 692/4028/67/2195 692/53/2421 Cancer Cancer Research Cell division Gene Therapy Human Genetics Hydrophobic surfaces Internal Medicine Medicine Medicine & Public Health Metabolism Oncology Precision medicine Targeted cancer therapy |
SummonAdditionalLinks | – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB7SBPo4lL7SuE3LFnpqWCpL1utoSkMwpJc0kJuYfWGDLQlLoqSn_PTO6JUaQ0oPOu1Ku9LMar7ZmfkW4DP5DOhjGklF1k-SxQtkopyVfLqxcczmorga-fJHdHE9W9yENwcwHWph2qT9ltKy_U0P2WFfKwIOXAw2pcuLUhk_gqOEtJOU-mg-X1wt7jdWCEOQ1RkimEGyf--uDdoDlvv5kWOQ9Bk8afISb3_hev2XHTp_Ac97ACnm3ZRfwoHNX8Hjyz5E_hrurprSbpe3ZluUy0KttCA5yyKXerkqxabbEqxExXCxLjZWMFND0e0Jira8SGBuRF-hVwkU5YDXf1sjOBVd4EjnKQon2DFGGl7UzYZm9wauz7___HYh-2MWpJ7FXi0j55NPFGKEiUt0pJgC3gXWqtDQX1RFyukwtOgC8i2Ul5KPhuj5qZ2FNp05H4NjOMyL3J6AIGNHHgeZu9gYrrHHJLZOaaVjg1obMwFv-PCZ7jnI-SiMddbGwoMk62SVkawyllUWT-DLeEvZEXA81Pl0kGbWr8UqI1CSxpw6Rs2fxmZaRRwawdwWDfWZBkmL1aIJvO2EP44WcNk9IdEJxDtqMXZghu7dlny1bJm6ufgmDWncs0GB7qf1wEucjTr271d-91_Pfg9PfV4HnMeYnsJhvW3sB0JVtfrYr6M_I68fwQ priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9AAceIhXoEWLxIlqg2vHXvtYoVYVEhUSBIWTtU8lIrGt2BZqT_x0ZvyCNFKrHnzaWe3Dszvf7M58C_AefQbpyyTiCq0fR4sX8Fg5y-l1Y-OIzUVRNvKXi-h8Nv08D-d7EPa5ME3QfkNp2WzTfXTYxxKBAyWDHePnRQkXk8K4e7Afheg0j2B_dvH15GfzkFwiOELoeX-DGcS7dbdt0A6w3I2PHC5JH8L9Oivk5W-5Wv1nh84ew49-BG34ya9JXamJvrpG7njnIT6BRx0yZSet4FPYs9kz-POtLuxmcWk2ebHI1VIz1BqeZ1wvlgVbtweMJSsJfFb52jLifcjbE0bWJCsxmRnW5fuVTLKiR_9X1jAKbGdyIAdluWPkZkuDDVX1Grv0HGZnp98_nfPu0Qaup8KreOR89LBCGcnYxTpSRCjvAmtVaHBPVpFyOgytdAF6KspL0OOT0vMTOw1tMnW-DF7AKMsz-woYmk70X9B4CmMoY1_GwjqllRZGam3MGLz-N6a6YzSnhzVWaXOzHsRpO6UpTmlKU5qKMXwYqhQtncdNwge9bqTdyi5ThDiJoEA0LH43FOOapIsWmdm8RpnjIG6QXzSGl60qDa0FlMSPuHYMYkvJBgHi-94uyZaLhvebUnmSENs96tXxX7duGMTRoLG3D_n1naTfwAOf1JWiIpMDGFWb2h4iRqvU225F_gWaVjrC priority: 102 providerName: Unpaywall |
Title | Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour |
URI | https://link.springer.com/article/10.1038/s41698-018-0069-7 https://www.ncbi.nlm.nih.gov/pubmed/30480095 https://www.proquest.com/docview/2389720017 https://www.proquest.com/docview/2138639936 https://pubmed.ncbi.nlm.nih.gov/PMC6242957 https://www.nature.com/articles/s41698-018-0069-7.pdf |
UnpaywallVersion | publishedVersion |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: DOA dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: M~E dateStart: 20170101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: RPM dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: NAO dateStart: 20171201 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: 7X7 dateStart: 20170101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: BENPR dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: AAJSJ dateStart: 20171201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 2397-768X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001851266 issn: 2397-768X databaseCode: C6C dateStart: 20171201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1La9tAEB4S-9D2UFr6iNrUbKGnhiWOXisdSnFNQjDUhKYG9yR2tbvYYEuqH5T01J_eGb0cE3AOukgrVquZ3fnmDfAJdQbpyjjkCqUfR4nn8UhZw6m7sbZUzUVRNvL3cXg98UfTYHoE4yYXhsIqmzOxPKh1npKN_BxFSywoAEh8LX5z6hpF3tWmhYasWyvoL2WJsWPo0pHsd6D77XJ882NndUGA4YZVx7lYcMTa08bV6UXna0QnlHF2gVc_jLnYF1YPEOjDQMrWm_oMnmyzQt79kYvFPYF19QKe10iTDSrWeAlHJnsF_263hVnN7vQqL2a5mqcMuYDnGU9n84ItK4Phmq0JTG7ypWFUxyGvLIasTD5iMtOszt9bM8mKBs3_NZpRoDqTbbFPlltGarPUONFmu8RPeg2Tq8ufw2teN2HgqS_6Gx5aFzWmQIYyslEaKioQbz1jVKDxjFWhsmkQGGk91DxUP0YNTsq-Gxs_MLFvXem9gU6WZ-YEGIpC1EdQGAqtKQNfRsJYlapUaKSf1g70m7-dpHWFcmqUsUhKT7kXJRWBEiRQQgRKhAOf21eKqjzHocGnDQmTeqeukx1fOfCxfYx7jBwnMjP5FsdceFGJ5EIH3lYUb2fzKCkfcaoDYo8X2gFUv3v_STaflXW8KTUnDnDes4Zrdp91YBFnLWM9vuR3h5f8Hp66xO0U1hifQmez2poPCLI2qgfHYip60B0MRrejXr2P8O4wHPZKwwXem4xvBr_-A_nXLEM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9FA4IBAvQ4FFggvVqq7fPlSIR6uUthGCVsrN3fWulUiJbWJbVTjxy_htzPgVokrh1ENO3mS9mdmdb3ZmvgF4iz6DsETocYnWj6PFs3kgE82pu7FKiM1FUjXy-cgbXjpfx-54C_50tTCUVtmdifVBrbKY7sj30bSEPiUA-R_yn5y6RlF0tWuhIdrWCuqwphhrCztO9fIaXbji8OQLyvudZR0fXXwe8rbLAI8d3yy5l1joErjCE0ESxJ4kBvTE1lq6Cg8R6ckkdl0tEhuhtTRDdFGEMK1QO64OncQSNv7uHdhG2GE5A9j-dDT69n11y4OAxvKaDnehzxHbj7vQqh3sF4iGqMLtAD-mF3J_3TjeQLw3Ezf76O092KnSXCyvxWz2j4E8fgD3W2TLPjaq-BC2dPoIfv-ocr2YLNUiyyeZnMYMtY5nKY8n05zNmwvKghUEXstsrhnxRmTNDSWri52YSBVr6wULJljeeQ-_tGKUGM9ETy7KsoSRmy4UTlRWc3ylx3B5K-J4AoM0S_UzYGh60f9B4-srRRX_IvB1ImMZ-wr1RSkDzO7fjuKWEZ0ac8yiOjJvB1EjoAgFFJGAIt-A9_1X8oYOZNPg3U6EUXsyFNFKjw140z_GPU2BGpHqrMIxB3ZQI0fPgKeNxPvZbCIBQFxsgL-mC_0A4gtff5JOJzVvOJUChS7Ou9dpzeq1Nixir1es_y_5-eYlv4ad4cX5WXR2Mjp9AXct0nxKqQx3YVAuKv0SAV4pX7W7iMHVbW_cv1_-Y4E |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7SFNL2EPrOtmmrQk8NSh17LdvHsO2SPhIKbSA3oye7sGubtU1IT_npmfErXRZSevBJsiV7NJ5vNDOfAD6gzyB9mQiu0PpxtHgBj5WznE43No7YXBRVI5-eiZPz8beL8GILwr4Wpknabygtm990nx32qUTgQMVgR3h5IuHRYWHcPbgfR4EgfZyIye3WCqIItDt9DDOIN-9et0Ib0HIzQ3IIkz6CB3VWyKtLuVj8ZYmmj2G3g5DsuJ30E9iy2VPYOe2C5M_g-ldd2NXsyqzyYparuWYoaZ5nXM_mBVu2m4IlKwkwVvnSMuJqyNtdQdYUGDGZGdbV6JVMsqJH7H-sYZSMzuRA6Mlyx8g1ljg8q-olzu45nE-__J6c8O6gBa7HkVdx4Xz0ikIpZOxiLRSRwLvAWhUa_I8qoZwOQytdgN6F8hL00qT0_MSOQ5uMnS-DF7Cd5ZndA4bmDn0ONHiRMVRlL-PIOqWVjozU2pgReP2HT3XHQk6HYSzSJhoexGkrqxRllZKs0mgEH4dbipaC467O-700004byxRhSRJR8hg2vx-aUY8oOCIzm9fY5yiIG7QmRvCyFf4wWkCF94hFRxCtLYuhA3F0r7dk81nD1U3lN0mI4x70C-h2Wne8xMGwxv79yq_-69nvYOfn52n64-vZ99fw0CeVoKTGZB-2q1Vt3yDEqtTbRqFuABUSIl4 |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9AAceIhXoEWLxIlqg2vHXvtYoVYVEhUSBIWTtU8lIrGt2BZqT_x0ZvyCNFKrHnzaWe3Dszvf7M58C_AefQbpyyTiCq0fR4sX8Fg5y-l1Y-OIzUVRNvKXi-h8Nv08D-d7EPa5ME3QfkNp2WzTfXTYxxKBAyWDHePnRQkXk8K4e7Afheg0j2B_dvH15GfzkFwiOELoeX-DGcS7dbdt0A6w3I2PHC5JH8L9Oivk5W-5Wv1nh84ew49-BG34ya9JXamJvrpG7njnIT6BRx0yZSet4FPYs9kz-POtLuxmcWk2ebHI1VIz1BqeZ1wvlgVbtweMJSsJfFb52jLifcjbE0bWJCsxmRnW5fuVTLKiR_9X1jAKbGdyIAdluWPkZkuDDVX1Grv0HGZnp98_nfPu0Qaup8KreOR89LBCGcnYxTpSRCjvAmtVaHBPVpFyOgytdAF6KspL0OOT0vMTOw1tMnW-DF7AKMsz-woYmk70X9B4CmMoY1_GwjqllRZGam3MGLz-N6a6YzSnhzVWaXOzHsRpO6UpTmlKU5qKMXwYqhQtncdNwge9bqTdyi5ThDiJoEA0LH43FOOapIsWmdm8RpnjIG6QXzSGl60qDa0FlMSPuHYMYkvJBgHi-94uyZaLhvebUnmSENs96tXxX7duGMTRoLG3D_n1naTfwAOf1JWiIpMDGFWb2h4iRqvU225F_gWaVjrC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Superhydrophobic+lab-on-chip+measures+secretome+protonation+state+and+provides+a+personalized+risk+assessment+of+sporadic+tumour&rft.jtitle=NPJ+precision+oncology&rft.au=Malara%2C+N.&rft.au=Gentile%2C+F.&rft.au=Copped%C3%A8%2C+N.&rft.au=Coluccio%2C+M.+L.&rft.date=2018-11-19&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2397-768X&rft.volume=2&rft_id=info:doi/10.1038%2Fs41698-018-0069-7&rft_id=info%3Apmid%2F30480095&rft.externalDocID=PMC6242957 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2397-768X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2397-768X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2397-768X&client=summon |